GL
NAUT icon

Governors Lane’s Nautilus Biotechnolgy NAUT Stock Holding History

Governors Lane’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-55,560
Closed -$561K – 217
2021
Q2 		$561K Sell
55,560
-137,692
-71% -$1.49M 0.04% 152
2021
Q1 		$2.66M Sell
193,252
-406,748
-68% -$5.64M 0.18% 114
2020
Q4 		$6.51M Hold
600,000
– – 0.55% 59
2020
Q3 		$6.49M Buy
+600,000
New +$6.4M 0.58% 59

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Governors Lane's NAUT Position: Q3 2021 in Review

Governors Lane sold out of Nautilus Biotechnolgy (NAUT) in Q3 2021, closing a stake of 55,560 shares — an estimated $561K sold.

Governors Lane first reported a position in NAUT in Q3 2020 and held it in 4 quarters. The position peaked at $6.51M in Q4 2020. 72 funds tracked by Wall St. Rank hold NAUT as of Q3 2021.

  • Governors Lane reported no remaining Nautilus Biotechnolgy position as of Q3 2021 after selling out during the quarter.
  • Governors Lane sold 55,560 Nautilus Biotechnolgy shares in Q3 2021, an estimated $561K.
  • Governors Lane first reported a position in Nautilus Biotechnolgy in Q3 2020 and held it in 4 quarters.
  • Governors Lane's Nautilus Biotechnolgy position peaked at $6.51M in Q4 2020.
  • 72 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q3 2021.

Based on Governors Lane's 13F filing for Q3 2021, filed 15 Nov 2021.